N@N

RNIN, FSI, GMA, SILC, PHA, URZ Are Seasonally Ripe To Go Up In the Next Five Weeks

^{Published on 2011-12-26 04:00:50 - WOPRAI}
 

December 26, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Wireless Ronin Technologies Inc (NASDAQ:RNIN), FLEXIBLE SOLUTIONS INTL INC (AMEX:FSI), GMAC LLC 7.30% Public Income Notes due March 9 2031 (NYSE:GMA), SILICOM LIMITED (NASDAQ:SILC), Pulte Homes Inc. 7.375% Senior Notes due June 1 2046 (NYSE:PHA), URANERZ ENERGY CORPORATION (AMEX:URZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     RNIN       Wireless Ronin Technologies Inc     20.43%              100.00% (5 of 5)        Monday, January 9th 2012
     FSI        FLEXIBLE SOLUTIONS INTL INC         9.83%               100.00% (8 of 8)        Tuesday, January 3rd 2012
     GMA        GMAC LLC 7.30% Public Income Notes due March 9 2031     4.30%               90.00% (9 of 10)        Thursday, February 2nd 2012
     SILC       SILICOM LIMITED                     29.58%              90.00% (9 of 10)        Tuesday, February 7th 2012
     PHA        Pulte Homes Inc. 7.375% Senior Notes due June 1 2046     6.18%               100.00% (5 of 5)        Wednesday, February 1st 2012
     URZ        URANERZ ENERGY CORPORATION          13.24%              66.67% (4 of 6)         Thursday, December 29th 2011

FLEXIBLE SOLUTIONS INTL INC (AMEX:FSI) - Flexible Solutions International, Inc., together with its subsidiaries, develops, manufactures, and markets specialty chemicals that slow down the evaporation of water. The company offers HEATSAVR, a chemical product for use in swimming pools and spas that forms a thin and transparent layer on the waters surface; ECOSAVR, a patented and disposable dispenser designed for residential pools and spas; and WATERSAVR to reduce water evaporation in reservoirs, potable water storage tanks, livestock watering ponds, aqueducts, canals, and irrigation ditches, as well as for lawn and turf care, and potted and bedding plants. It also offers WATERSAVRBTI that combines evaporation control with an environmentally friendly method of killing mosquito larvae. In addition, Flexible Solutions offers thermal polyaspartate biopolymers (TPAs) for oil fields to reduce scale and corrosion in various water systems; TPAs for the agricultural industry to reduce fertilizer crystallization before, during, and after application, and also prevent crystal formation between fertilizer and minerals present in the soil; TPAs for irrigation; TPAs for detergents as a biodegradable substitute for poly-acrylic acid; and TPAs for personal care products, which can be used in shampoo and cosmetic products. The company was founded in 1991 and is based in Victoria, Canada.

GMAC LLC 7.30% Public Income Notes due March 9 2031 (NYSE:GMA) - GMAC LLC 7.30% Public Income Notes due March 9 2031

SILICOM LIMITED (NASDAQ:SILC) - Silicom Ltd. (Silicom), incorporated in 1987, is engaged in the design, manufacture, marketing and support of connectivity solutions for a range of computer users. The Company is active in high-end server networking cards, high-end networking bypass cards, connectivity solutions for portable personal computers (PCs) and broadband Internet access. In high-end server networking cards, Silicom is able to leverage its expertise in networking and operating systems. In high-end networking Bypass cards, the Company produces server-networking cards with special functionalities for security appliances and it leverages its server networking cards for the growing security market. Connectivity solutions for portable PCs is Silicom's traditional area of expertise, in which demand for its products has declined and in which it expects to phase out over time. In broadband Internet access, the Company leveraged its technology and connectivity solutions know-how but operations in this industry are declining as well.

High end Server Networking Cards

The Company has developed a line of products for the evolving server networking industry, which facilitates interaction between servers, allowing them to communicate with each other. The products Silicom has developed use its Ethernet and operating systems expertise. The first products in this line are eight multi-port, gigabit-Ethernet, server-networking cards. These are products that allow server-based systems to exploit the potential of gigabit Ethernet. The products have either two, four or six ports, which plug into the servers between which interaction is facilitated. Silicom's business model for its server networking lines of products is called the Design Win Model. It is based on the exploitation of the Company's intellectual property relating to connectivity solutions and networking.

The Company's competitor in this area is Intel.

High-end Networking Bypass Cards for Security and other Network Appliances

Following the production of its Server Networking Cards, Silicom developed some of these same products with a bypass feature. Intended for mission-critical environments, the Silicom Gigabit Ethernet Bypass Networking Cards feature bypass circuitry to maintain continuity of network connectivity in the event of a gateway failure. The products are divided into two groups. One group of products is based on Broadcom's chipset and the other group is based on Intel's chipset. Products based on Broadcom's chipset are PXG6, PXG4, PXG2, PXG2F, PEG1, PEG1F, PXG2BP, and PXG4BP. The number in each product name represents the number of gigabit-Ethernet ports.

In April 2004, the Company announced the release of its products, which is based on a transmission control protocol/ /Internet protocol (TCP/IP) offload engine (TOE) solution. Multi-port gigabit-Ethernet cards can work at high speeds, but in some cases, they bring the central processing unit (CPU) utilization of the host-server to almost 100%. Silicom's TOE (TCP/IP Offload Engine)/ Internet small computer systems interface (iSCSI) server adapters are designed to accelerate server performance through the elimination of server-CPU bottlenecks by handling computation-intensive tasks, which releases the CPU of the host-server and allows it to deal with its original missions.

Silicom's competitors in this segment include Alacritec, Inc., Adaptec Inc., Emulex Inc., Qlogic Inc., and JNI Inc.

Traditional Connectivity Solutions for Portable PCs

In the field of portable computers, the Company's strength has been its range of single and multi-function connectivity products that incorporate various Silicom and third-party technologies to provide portable computer users with a solution to their connectivity problems. The trend in the data communications industry has been to incorporate modems as built-in elements of portable PCs, and to incorporate Ethernet and fast Ethernet as built-in elements of portable PCs. Both these trends have obviated much of the need for Silicom's modem and Ethernet/Fast Ethernet PC card products. The M

Pulte Homes Inc. 7.375% Senior Notes due June 1 2046 (NYSE:PHA) - Pharmacia Corporation, formed in 2000, is primarily involved in the development, manufacturing and sale of pharmaceutical products. Prescription pharmaceuticals is the Company's only business segment and includes general therapeutics, ophthalmology and hospital products, including oncology and diversified therapeutics. The Company also operates several business units that do not constitute reportable business segments. These operating units include, among others, consumer healthcare, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. Due to the size of these operating units, they have been grouped into the Other Pharmaceuticals category. The Company's products are sold throughout the world to a wide range of customers, including pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. In April 2003, the Company completed its merger with and into Pfizer. Pharmacia and Pfizer's combined operations create a research-based pharmaceutical company.

Prescription Pharmaceuticals

The Company's leading prescription products include Celebrex, Xalatan, Genotropin, Camptosar, Detrol LA and Zyvox. Celebrex, a cyclooxygenase-2 (COX-2) specific inhibitor, is a nonsteroidal anti-inflammatory drug, and is used for the treatment of osteoarthritis, adult rheumatoid arthritis, acute pain and primary dysmenorrhea. Celebrex is available in over 70 countries and is co-promoted (or, where required by law, co-marketed) by Pfizer, Inc. in the United States and Europe, and will be co-promoted by Yamanouchi when approved in Japan.

Xalatan, the Company's branded intraocular pressure (IOP) lowering agent, is used in the treatment of open-angle glaucoma and ocular hypertension in patients insufficiently controlled on other medications. During 2001, Xalacom, a fixed combination of Xalatan and the beta-blocker timolol, was approved in Sweden and the European Union, where it is marketed under the name Xalacom. The Company continues to seek approval of Xalcom in the United States after receiving a third approvable letter from the Food and Drug Administration (FDA). Xalcom provides a greater reduction in intraocular pressure.

Genotropin, a recombinant human growth hormone, is used to treat adults with growth hormone deficiency and to treat growth failure in children with growth hormone deficiency. In 2000, Genotropin was also approved for the treatment of growth failure in children with Prader-Willi Syndrome (PWS), and in 2001, it was approved for use with children who were born small for gestational age (SGA) who have not caught up in growth by age two. Genotropin has been granted orphan drug status by the FDA for both PWS and SGA. Adding to the Company's endocrine treatment business, in early 2001, it completed its acquisition of Sensus Drug Development Corporation, which filed a New Drug Application (NDA) with the FDA for pegvisomant, a growth hormone receptor antagonist. Pegvisomant is being reviewed for the treatment of acromegaly, a life-threatening disorder caused by overproduction of growth hormone.

Camptosar, a first-line therapy in metastatic colorectal cancer, is a treatment for colorectal cancer. The product was in-licensed from Yakult Honsha Co. for marketing in the United States. In addition to Camptosar, the Company markets several other oncology drugs. Pharmorubicin is a commonly used treatment for breast cancer in Europe, and is marketed under the trade name Ellence in the United States for the adjuvant treatment of patients with breast cancer. Aromasin, an oral hormonal drug that blocks the production of estrogen, was launched during 2000 in the United States and in key markets in Europe and Latin America as a second-line breast cancer treatment. The Company's subsidiary, Sugen, Inc., has developed proprietary technology platforms to identify small molecule drugs that target specific cellular signal transduction pathways and may have oncological or other therapeutic uses. Pharmacia announced, on February 8, 2002, that it was closing its SU541

URANERZ ENERGY CORPORATION (AMEX:URZ) - Uranerz Energy Corporation, an exploration stage company, engages in the acquisition, exploitation, and development of uranium properties. The company principally focuses on the exploration of its properties in the Powder River Basin area of Wyoming encompassing approximately 119,312 acres, as well as owns interests in properties located in the Great Divide Basin area of Wyoming, Texas and in Saskatchewan, Canada. The company was formerly known as Carleton Ventures Corp. and changed its name to Uranerz Energy Corporation in July 2005. Uranerz Energy Corporation was founded in 1999 and is based in Casper, Wyoming.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641